What KLOW is and what it is studied for
The KLOW pen holds four peptides: BPC-157 5 mg and TB-500 5 mg — the Wolverine repair pairing — plus GHK-Cu 25 mg, the copper-binding tripeptide studied for collagen and wound healing that defines the GLOW pen, and KPV 5 mg, a tripeptide fragment of alpha-MSH studied for its anti-inflammatory effect in the gut lining and in skin. The K is the only thing that separates it from GLOW, and it is the reason it exists.
The research interest is a quieter inflammatory baseline underneath repair: soft tissue that settles and stays settled, skin that calms rather than flares, a gut that stops being the thing that derails everything else. Like GLOW, nothing about KLOW is fast. The protocol below is built around the GHK-Cu ceiling — copper must be cleared, not maximised — and around the fact that every click moves four compounds at once, so the dial is turned conservatively.
Who it suits — and who should not run it
Written for the adult researcher with a repair or skin goal who also carries a low-grade inflammatory picture — a gut that reacts, skin that flares, joints that take longer than they should — and who has had that picture assessed. Baseline copper and ceruloplasmin are non-negotiable before the first click. The house exclusions:
Not for
- Active cancer or a recent history of cancer — the repair peptides and GHK-Cu work through growth-signalling pathways.
- Wilson's disease or any other known disorder of copper metabolism.
- Pregnant, breastfeeding, or planning pregnancy in the next 6 months.
- Under 18.
- An undiagnosed gut or skin condition — assessment first; the pen does not tell you what is wrong.
- A known hypersensitivity to any of the four peptides in the pen.
The house protocol
Once daily, five days a week (Monday–Friday), subcutaneous in the abdomen a hand's width from the navel, rotating the site every day, in the evening. Five on, two off is the house rhythm for the whole cycle, exactly as for GLOW. One pen = 300 clicks; each click delivers 16.7 mcg BPC-157 + 16.7 mcg TB-500 + 16.7 mcg KPV + 83.3 mcg GHK-Cu.
Two phases: a two-week run-in at a dose that keeps every compound at the bottom of its window, then a ten-week hold at the working dose with no further step-ups. The hold dose puts BPC-157, TB-500 and GHK-Cu at the same per-day amounts as the GLOW hold, with KPV riding alongside at 333 mcg — inside its 200–500 mcg daily window.
| Pen | Dose per injection | Clicks | Frequency | Timing | Cycle |
|---|---|---|---|---|---|
| KLOW 5 + 5 + 5 + 25 mg | 250 mcg BPC-157 + 250 mcg TB-500 + 250 mcg KPV + 1.25 mg GHK-Cu | 15 | Daily, Monday–Friday | Evening | Weeks 1–2 — run-in |
| KLOW 5 + 5 + 5 + 25 mg | 333 mcg BPC-157 + 333 mcg TB-500 + 333 mcg KPV + 1.67 mg GHK-Cu | 20 | Daily, Monday–Friday | Evening | Weeks 3–12 — hold |
| Ceiling | 400 mcg of each peptide + 2 mg GHK-Cu | 24 | — | — | Never exceeded with this combination |
Click total: 10 days × 15 = 150, plus 50 days × 20 = 1,000, for 1,150 clicks → 4 pens (1,200 clicks), leaving 50 clicks at the end of the cycle. The pen is a quarter the strength of GLOW per click, which is why the click counts are higher for the same doses — check the pen name before turning the dial. Keep it in the fridge between uses.
Mild injection-site redness or itch from GHK-Cu is common in the run-in weeks and is not a reason to stop. A lump, spreading heat or warmth around the site is not normal and is a same-day message to your coach. A metallic taste together with nausea and fatigue is the signal to stop and call.
Week by week — what people typically notice and when
| When | What is typically reported |
|---|---|
| Weeks 1–2 (run-in) | Mild site redness or itch is common. The gut is usually the first thing researchers notice — fewer reactive days — and training recovery often improves from week 2. |
| Weeks 3–5 | Skin that flared tends to calm before it visibly improves. Soft-tissue niggles that kept returning start to stay settled. |
| Weeks 6–10 | Skin texture, hydration and tone move through this window, as on GLOW. Joint and tendon load tolerance improves in step with training. |
| Weeks 8–12 | Hair shedding tends to reduce; visible regrowth usually lags beyond the cycle. The inflammatory picture is judged on the week-12 CRP and calprotectin, not on feel. |
| Throughout | Response varies; four compounds working gradually is still gradual. Nothing on KLOW is sudden. |
SPF every morning without exception — GHK-Cu's collagen and tone benefits are undone by unprotected sun. No new foods, retinoids or skin actives in the same week as the pen, so that a flare can be attributed to something. The gut plan agreed with your physician stays in place: KPV is studied for calming the lining, not for making trigger foods safe. Training is unchanged.
Labs we ask for before and during
| Marker | When | Why it is on the list |
|---|---|---|
| Serum copper, ceruloplasmin | Baseline · week 12 | GHK-Cu adds a daily copper load; the recheck confirms it is clearing normally |
| Zinc | Baseline | Copper and zinc compete for absorption; a starting point matters |
| CRP | Baseline · week 12 | The inflammatory baseline KPV is on the pen to address |
| Faecal calprotectin | Baseline · week 12 (gut target) | The objective read on gut-lining inflammation |
| Full blood count | Baseline | General safety baseline before a 12-week cycle |
| Liver panel (ALT, AST, GGT, bilirubin) | Baseline | Copper is cleared through the liver |
| Cystatin C (never creatinine alone) | Baseline | Kidney measure not distorted by muscle or creatine |
The week-12 copper and ceruloplasmin recheck is the most important number this protocol produces — do not skip it. CRP and calprotectin at week 12 are how the K in KLOW is judged. No copper supplements for the duration, and no high-dose zinc changes without your physician. Vitamin D, magnesium and omega-3 remain the only general supplements.
Stacking: what it pairs with
KLOW is the most complete pen in the library and is run alone. It already contains everything in Wolverine and GLOW, and the single BPC-157, TB-500, GHK-Cu and KPV pens — so none of those is added on top. Choose GLOW when inflammation is not part of the picture; choose KLOW when it is.
What does pair with it works on a different axis: a nightly CJC-1295 + Ipamorelin pairing for recovery sleep, or thymosin alpha-1 twice a week for the researcher whose inflammatory picture has an immune component. The copper rule does not change with any addition, and spacing between KLOW cycles is a personalised-protocol decision.
Common mistakes
- Using GLOW click counts on a KLOW pen. KLOW is a quarter the strength per click. Ten clicks of KLOW is a run-in dose, not a hold dose.
- Skipping baseline copper and ceruloplasmin. Twelve weeks of daily copper without a starting point is guessing.
- Going past 24 clicks. The hold dose is 20 clicks (1.67 mg GHK-Cu); 24 clicks (2 mg) is the ceiling, not a target.
- Adding a single BPC-157, TB-500, GHK-Cu or KPV pen on top. All four are already in every click.
- Changing diet, skincare and the pen in the same week. When something flares, you need to know what caused it.
- Judging the K on feel. The inflammatory effect is read on week-12 CRP and calprotectin, not on a good or bad gut day.
Frequently asked questions
How many clicks is a KLOW dose?
15 clicks a day for the two-week run-in (250 mcg each of BPC-157, TB-500 and KPV plus 1.25 mg GHK-Cu), then 20 clicks a day for weeks 3–12 (333 mcg of each plus 1.67 mg GHK-Cu). Never more than 24 clicks a day with this combination.
What is in each click of the KLOW pen?
16.7 mcg BPC-157, 16.7 mcg TB-500, 16.7 mcg KPV and 83.3 mcg GHK-Cu. One pen holds 300 clicks and a 12-week cycle uses four pens.
What is the difference between KLOW and GLOW?
KPV. GLOW is BPC-157, TB-500 and GHK-Cu for repair, skin and hair; KLOW adds KPV, an anti-inflammatory tripeptide studied in the gut lining and skin. GLOW is also twice the strength per click, so the click counts differ. The two are never run together.
Why does KLOW need copper labs?
GHK-Cu adds a copper load every injection day for 12 weeks. Serum copper and ceruloplasmin at baseline and week 12 confirm it is clearing normally; anyone with Wilson's disease or another copper-metabolism disorder should not run KLOW at all.
When does KLOW show results?
Gut reactivity is usually the first change, in the run-in weeks; skin calms around weeks 3–5 and improves in texture and tone through weeks 6–10; hair shedding reduces around weeks 8–12. The inflammatory effect is judged on labs at week 12.
Want this written for your body, not the average one?
The personal research protocol (€399, follow-up included) takes your intake, puts it through human review, and returns a short results version plus the full clinical document — then a free coach call on WhatsApp to walk it through and read your labs against the plan.
Build my protocol Book a 15-minute call